|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Oversikt over luftvegsprøver, Mikrobiologisk
avdeling, HUS. |
2020-2021 |
|
|
Inneliggjande pasientar |
Veke 21-39 |
|
Veke 21-38 |
|
Veke 21-37 |
|
Veke 21-36 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Bordetella parapertussis |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Mycoplasma pneumoniae |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Chlamydia pneumoniae |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Influensavirus A |
391 |
<5 |
|
|
408 |
<5 |
|
|
418 |
<5 |
|
|
419 |
<5 |
|
|
|
Influensavirus B |
391 |
<5 |
|
|
408 |
<5 |
|
|
418 |
<5 |
|
|
419 |
<5 |
|
|
|
Parainfluensavirus 1 |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Parainfluensavirus 2 |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Parainfluensavirus 3 |
170 |
20 |
12 % |
|
157 |
17 |
11 % |
|
150 |
12 |
8 % |
|
150 |
6 |
4 % |
|
|
Respiratorisk syncytialt virus |
311 |
9 |
3 % |
|
383 |
6 |
2 % |
|
258 |
<5 |
|
|
274 |
<5 |
|
|
|
Humant metapneumovirus |
170 |
<5 |
|
|
157 |
<5 |
|
|
150 |
<5 |
|
|
150 |
<5 |
|
|
|
Rhinovirus |
170 |
14 |
8 % |
|
157 |
25 |
16 % |
|
150 |
27 |
18 % |
|
150 |
13 |
9 % |
|
|
SARS-CoV-2 |
451 |
<5 |
|
|
486 |
5 |
1 % |
|
494 |
<5 |
|
|
499 |
<5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ambulante pasientar |
Veke 21-39 |
|
Veke 21-38 |
|
Veke 21-37 |
|
Veke 21-36 |
|
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
Totalt |
Påvist |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bordetella pertussis |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Bordetella parapertussis |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Mycoplasma pneumoniae |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Chlamydia pneumoniae |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Influensavirus A |
477 |
<5 |
|
|
437 |
<5 |
|
|
390 |
<5 |
|
|
436 |
<5 |
|
|
|
Influensavirus B |
477 |
<5 |
|
|
437 |
<5 |
|
|
390 |
<5 |
|
|
436 |
<5 |
|
|
|
Parainfluensavirus 1 |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Parainfluensavirus 2 |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Parainfluensavirus 3 |
470 |
133 |
28 % |
|
425 |
100 |
24 % |
|
386 |
70 |
18 % |
|
402 |
61 |
15 % |
|
|
Respiratorisk syncytialt virus |
477 |
24 |
5 % |
|
435 |
15 |
3 % |
|
388 |
13 |
3 % |
|
416 |
17 |
4 % |
|
|
Humant metapneumovirus |
470 |
<5 |
|
|
425 |
<5 |
|
|
386 |
<5 |
|
|
402 |
<5 |
|
|
|
Rhinovirus |
470 |
108 |
23 % |
|
425 |
108 |
25 % |
|
386 |
106 |
27 % |
|
402 |
117 |
29 % |
|
|
SARS-CoV-2 |
7003 |
150 |
2 % |
|
11514 |
167 |
1 % |
|
14571 |
211 |
1 % |
|
20459 |
382 |
2 % |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Inneliggjande pasientar omfatter fleire
sjukehus i vår region |
|
|
|
|
|
|
|
07.10.2021 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|